U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: August 21-27, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: August 21-27, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 08/21/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: COURTNEY BUCHANAN; FRANK YIANNAS;
Non FDA Participant/Group: Monica Wilkins, Robert Ford (Abbott Laboratories);

Event Date: 08/23/2022
Location: Virtual
Subject: Health Equity
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several members of the Alliance of Multicultural Physicians

Event Date: 08/24/2022
Location: Virtual
Subject: Accelerating Access to Critical Therapies for Amyotrophic Lateral Sclerosis Act
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, industry, media, and other registered attendees

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 08/25/2022
Location: Mexico City, Mexico
Subject: U.S. and Mexico Food Safety Partnership Annual Meeting; Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several leaders and staff from the following Mexican government agencies: National Service of Agro-Alimentary Health, Safety and Quality; and the Federal Commission for Protection from Sanitary Risks

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 08/22/2022
Location: San Jose, Costa Rica
Subject: National Commission Against Illicit and Counterfeit Products (CONAPIF)
FDA Participant/Group: KATHERINE SERRANO;
Non FDA Participant/Group: Daisy Maria Corrales (Ministry of Health);

Event Date: 08/25/2022
Location: Mexico City, Mexico
Subject: Introductory Meeting
FDA Participant/Group: KATHERINE SERRANO;
Non FDA Participant/Group: Alejandro Svarch (Federal Committee for Protection from Sanitary Risks);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 08/26/2022
Location: Virtual
Subject: Monkeypox Therapeutics
FDA Participant/Group: ANDREW LEBOEUF; CHRISTOPHER CAMPBELL; HILARY MARSTON; JULIA TIERNEY; JOHN FARLEY; ADAM SHERWAT;
Non FDA Participant/Group: Anne Zink, James McDonald, John Hellerstedt, Kathleen Toomey, Manisha Juthani, Mary Bassett, Nirav Shah, Steven Stack, Umair Shah (Association of State and Territorial Health Officials (ASTHO)); Adriana Andrade, Sarah Read (National Institute of Allergy and Infectious Diseases (NIAID));

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 08/24/2022
Location: Virtual
Subject: Dialysis Machine Distribution
FDA Participant/Group: MICHAEL HOFFMANN; KATHLEEN WHITE; COURTNEY LIAS; JOYCE WHANG; DOUGLAS SILVERSTEIN; TAMMY BECKHAM; GLENN BELL; GEMA GONZALEZ; DOUGLAS KELLY
Non FDA Participant/Group: David Mahoney, Jeffrey Giullian, Joelle Thornhill, Kayla Amodeo (DaVita);

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 08/23/2022
Location: Virtual
Subject: Efforts Around Improving Health Through Nutrition
FDA Participant/Group: RICHARDAE ARAOJO; ROBIN MCKINNON;
Non FDA Participant/Group: Danielle Turnipseed, Debra Cohn, Shannon Curtis (American Medical Association);

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 08/23/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: ANNE NORRIS; KATHERINE HUEBNER; AMBER MCCOIG; SUSAN BRIGHT-PONTE; NEAL BATALLER; ERROL STRAIN; PATRICK MCDERMOTT; JOSHUA HAYES; WILLIAM FLYNN; NADINE STEINBERG; TIMOTHY SCHELL; CINDY BURNSTEEL; JEFFREY GILBERT; REGINA TAN; CHARLI LONG; HEATHER TATE; ANTONIA MONIQUE SENNETT; CHRIS WHITEHOUSE; ASHLEY STEEL; JOHN MUSSMAN; MATTHEW LUCIA; SIOBHAN DELANCEY;
Non FDA Participant/Group: Representatives from Keep Antibiotics Working (KAW)

Event Date: 08/25/2022
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: WILLIAM FLYNN; ANTONIA MONIQUE SENNETT; TRACEY FORFA;
Non FDA Participant/Group: Representatives from American Association of Veterinary Medical Colleges (AAVMC)

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top